Objective: Retained product of conception is an important cause of irregular vaginal bleeding that may lead to infection and anemia. Surgical evacuation remained the treatment of choice for long but alternate management options like expectant and medical management have also been found effective and preferred by many women. This intervention study was aimed to evaluate the outcomes of expectant and medical treatment for retained product of conception. Methods: Fifty (50) patients with retained product of conception were included from January:to December, 2010. Pre-tested structured questionnaire was used to record demographic and obstetrical history. Expectant and medical treatment modalities were applied to patients based on the ultrasonographic size of product of conception and post-treatment outcomes were observed after one month. Results: Majority of patients (70%) was 25-35 years of age, 70% were multigravid, 72% had history of spontaneous abortion and 28% gave history of menstrual regulation (MR) and/or dilatation and curettage (D&C) in the past. Frequency distribution of different sizes of product of conception were 16% (<1 cm), 44% (1-2 cm), 36% (3-4 cm) and 04% (>4 cm) as detected in sonographic examination. Treatment modalities included expectant for 08 (16%), misoprostol and haematinic for 22 (44%) and misoprostol, antibiotic and haematinic for 20 (40%) cases respectively. Overwhelming majority (96%) recovered completely with medical treatment as revealed by normal sonographic findings at one month follow up and only 4% required other methods whose products of conception were >4 cm in size. Conclusion: Medical management is a good alternative to conventional surgical method for retained products of conception in properly selected patients and it has excellent patient compliance.